July 2012 Newsletter

July 16, 2012:

Cataract Surgery Constrained by Eurozone Austerity

Budget reductions in Europe are leading to fewer cataract procedures, and the weak economy could lead to more cutbacks.

July 16, 2012:

Glaucoma Meeting Focuses on Emerging MIGS Field

This year’s meeting looked at the science behind minimally invasive glaucoma surgery (MIGS) and debated the classification of techniques.

July 16, 2012:

After Years in Limbo, Glaukos iStent Finally Receives FDA Regulatory Approval

The stent is the first such device approved for use in combination with cataract surgery to reduce IOP in adult patients with mild or moderate open-angle glaucoma.

July 16, 2012:

US Glaucoma Survey Highlights Dependence on Medications

Medications are still the focus for treating glaucoma patients, according to a recent Market Scope survey of US glaucoma specialists.

July 16, 2012:

Increasing Adoption of Ultrasonic Phaco and LRCS Will Lead to 11 Percent Growth Annually through 2017

Global revenues will reach $1.1 billion in 2012, with ultrasonic phaco machines, dedicated machine packs, and accessories making up 86 percent of revenues.

July 16, 2012:

July 2012 News Briefs

This month's news includes the latest from QLT Inc., Abbott Medical Optics, Bausch + Lomb, LensAR, Alimera Sciences, Optimedica, Mobius Therapeutics, and StemCell's, Inc.

Social media